Medtronic (FRA:2M6) Beta: 0.7459 (As of Jun. 25, 2026)


FRA:2M6 Medtronic PLC FRA:2M6
78 GF Score
Price €70.74
GF Value €87.73
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medtronic Beta?

Medtronic FRA:2M6 78 Beta is 0.7459 as of Jun. 25, 2026. GuruFocus rates FRA:2M6 with a GF Score™ of 78/100 and a GF Value™ of €87.73 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Medtronic's Beta is 0.7459.


Medtronic  (FRA:2M6) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Medtronic Beta Related Terms


Medtronic Beta Historical Data

* Premium members only.

The historical data trend for Medtronic's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic Beta Chart

Medtronic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.56 0.58 0.76 0.82 0.85

Medtronic Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.82 0.72 0.75 0.95 0.85

FRA:2M6 vs SYK, BSX, EW: Beta Comparison

For the Medical Devices subindustry, Medtronic's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medtronic Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Beta distribution charts can be found below:

* The bar in red indicates where Medtronic's Beta falls into.


FRA:2M6
78GF Score
Medtronic PLC FRA:2M6
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtronic Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.7459 mean?
Medtronic (FRA:2M6) has a Beta of 0.7459 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Medtronic and its competitors.
Is Medtronic's Beta too high?
Medtronic's current Beta is 0.7459. Overall, Medtronic has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's Beta compare to SYK and BSX?
Medtronic's Beta of 0.7459 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Medtronic and its competitors. Medtronic's current Beta is 0.7459. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (FRA:2M6) is currently considered Modestly Undervalued. The stock's GF Value™ is €87.73, compared to a current price of €70.74 — trading 19.4% below its estimated fair value. The current Beta is 0.7459. Medtronic's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Medtronic (FRA:2M6), the current Beta is 0.7459 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medtronic (FRA:2M6) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of €70.74 is trading 19.4% below its estimated GF Value™ of €87.73. GuruFocus considers Medtronic to be Modestly Undervalued.

Key valuation signals for FRA:2M6:

  • Beta: 0.7459
  • GF Value™: €87.73 vs. price of €70.74 (19.4% below fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the FRA:2M6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
78GF Score

Get the complete analysis for FRA:2M6

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€70.74
Price
€87.73
GF Value